Mundipharma A/S: Financial statements 2021
CVR: 17981994
Source: annual report 2021, Danish Business Authority
01/01/2021 – 31/12/2021
Mundipharma A/S (CVR 17981994) has filed annual accounts for 2021. In 2021, the company reported revenue of DKK 48,452,861 and a net result of DKK 909,958 compared with DKK 908,000 the year before. That is a decrease of 6% compared with the year before. The profit margin was 1.9%. Equity in the 2021 report amounted to DKK 49,127,664. The solvency ratio was 57.3%. The company had 9 employees in the financial year.
- Revenue
- DKK 48,452,861
- Gross Profit
- DKK 10,461,368
- Profit/Loss
- DKK 909,958
- Equity
- DKK 49,127,664
- Total Assets
- DKK 85,665,923
- Employees
- 9
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2021 | 48.5M | 10.5M | 910K | 49.1M | 9 |
| 2020 | 51.6M | 30.8M | 908K | 48.2M | 21 |
| 2019 | 53.5M | 27M | 23K | 47.3M | 25 |
| 2018 | 55.4M | 24.9M | -152K | 47.3M | 26 |
| 2017 | 63.3M | 25.4M | -8.3M | 47.4M | 23 |
Official annual report
Find more companies like Mundipharma A/S
Build lead lists with filters on industry, geography, size and financials, and export straight to Excel.
Try the lead list generatorEvents in 2021
As of December 3, 2021, Jennie Maria Synnöve Tjernström is registered as adm. dir. of Mundipharma A/S.
As of December 3, 2021, Salvador Lopez Orland has stepped down as adm. dir. of Mundipharma A/S.
Mundipharma A/S has published its annual report for 2020. Revenue came to DKK 51,563,000, and the net result was DKK 908,000.
As of January 22, 2021, Salvador Lopez Orland has joined the board of directors of Mundipharma A/S.
As of January 22, 2021, Kjetil Kollstad has left the board of directors of Mundipharma A/S.
As of January 15, 2021, Salvador Lopez Orland is registered as adm. dir. of Mundipharma A/S.
As of January 15, 2021, Kjetil Kollstad has stepped down as adm. dir. of Mundipharma A/S.
About Mundipharma A/S
Mundipharma A/S is a Danish company of the type Aktieselskab based in Vedbæk, founded in 1994. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named Norpharma A/S and NORPHARMA A/S. The management consists of Lisbeth Kattenhøj. The board consists of Stephen Johan Jamieson (chair), Bryan George Lea and Lisbeth Kattenhøj. The company is owned by Halm S.à.r.l., RSS Captain Trust Holdings LLC and JDS Captain Trust Holdings LLC. The company has 3 employees (2026). In 2025, the company reported revenue of DKK 25,912,000 and a net result of DKK 672,000 compared with DKK 514,000 the year before. Equity in the 2025 report amounted to DKK 38,165,000.
